Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
Seeking Alpha
Tuesday, March 19, 2013 - 10:54am
tags:
NovaBay Pharmaceuticals, auriclosene, Galderma
Novo Nordisk hit by insulin drug doubts, downgrade
Marketwatch
Tuesday, March 19, 2013 - 10:53am
tags:
insulin, Novo Nordisk, Tresiba
Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer
Yahoo
Tuesday, March 19, 2013 - 10:52am
tags:
Apricus Biosciences
Cardiome Posts 4Q Profit
Yahoo/Zacks
Tuesday, March 19, 2013 - 10:51am
tags:
earnings, Cardiome
3 Big Concerns for the Pharmaceutical Industry
Motley Fool
Tuesday, March 19, 2013 - 10:46am
tags:
generics, drug pricing, Bristol-Myers Squibb, Eli Lilly, GSK, Questcor, KV Pharmaceutical, Sinovac Biotech, Dendreon
Cordis acquires Flexible Stenting Solutions, terms not disclosed
Yahoo/Fly on the Wall
Tuesday, March 19, 2013 - 10:44am
tags:
Cordis, M&A, Flexible Stenting Solutions
Boehringer Ingelheim and Lilly initiate MARLINA clinical trial to evaluate use of Tradjenta® (linagliptin) tablets in patients with type 2 diabetes and albuminuria
Yahoo
Tuesday, March 19, 2013 - 10:43am
tags:
Eli Lilly, Boehringer Ingelheim, Tradjenta, diabetes, albuminuria
Star Scientific Subpoenaed by U.S. Attorney's Office
TheStreet.com
Tuesday, March 19, 2013 - 10:42am
tags:
Star Scientific
No Quick Fixes, But Astra's Soriot Can Still Be Bold
Seeking Alpha
Tuesday, March 19, 2013 - 10:41am
tags:
AstraZeneca, Pascal Soriot, restructuring
Is Pfizer Still a Big Pharma Kingpin?
Motley Fool
Tuesday, March 19, 2013 - 10:40am
tags:
Pfizer
AbbVie-Receptos Collaborate
Yahoo/Zacks
Tuesday, March 19, 2013 - 10:39am
tags:
Receptos, AbbVie, RPC4046, asthma
AstraZeneca restructuring will eliminate 1,600 jobs in US, UK and relocate global HQ by 2016
Yahoo/AP
Tuesday, March 19, 2013 - 10:38am
tags:
AstraZeneca, restructuring, layoffs
Intercept's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, March 19, 2013 - 10:37am
tags:
earnings, Intercept Pharma
Eli Lilly says study of Cialis co-administered with Finasteride meets endpoint
Yahoo/Fly on the Wall
Monday, March 18, 2013 - 12:37pm
tags:
Cialis, Eli Lilly, finasteride, benign prostatic hyperplasia
Novo Nordisk Says Trial Shows Victoza Helps Patients Lose Weight
Bloomberg
Monday, March 18, 2013 - 11:22am
tags:
Novo Nordisk, Victoza, obesity, diabetes
CombiMatrix Potential Turnaround
Seeking Alpha
Monday, March 18, 2013 - 11:18am
tags:
CombiMatrix
3 Companies Developing Novel Cancer Drug Delivery Platforms
Seeking Alpha
Monday, March 18, 2013 - 11:10am
tags:
drug delivery, cancer, Celgene, AngioDynamics, OncoSec
Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Yahoo/AP
Monday, March 18, 2013 - 11:09am
tags:
Galena Biopharma, Abstral, cancer pain, Orexo
Novartis says Alcon's eye drug Jetrea gets EU approval
Yahoo/Reuters
Monday, March 18, 2013 - 11:08am
tags:
Novartis, Europe, Alcon, Jetrea, vitreomacular traction
AstraZeneca sees R&D restructuring to result in $1.4B in charges
Yahoo/Fly on the Wall
Monday, March 18, 2013 - 11:00am
tags:
R&D, AstraZeneca, restructuring

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.